Biofrontera Inc. — Director's Dealing 2021

Dec 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Biofrontera Inc. (BFRI)
CIK: 0001858685
Period of Report: 2021-12-09

Reporting Person: Monaco Erica L. (Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-09	Restricted Stock Units	$	A	56689	Acquired		Common Stock (56689)	Direct
2021-12-09	Employee stock option (right to buy)	$4.41	A	56689	Acquired	2031-12-09	Common Stock (56689)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of BFRI common stock.

F2: The restricted stock units vest on June 9, 2022. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.

F3: The option vests in three equal annual installments beginning on December 9, 2022.